Cataplexy-related neurons in the amygdala of the narcoleptic dog

S Gulyani, MF Wu, R Nienhuis, J John, JM Siegel - Neuroscience, 2002 - Elsevier
S Gulyani, MF Wu, R Nienhuis, J John, JM Siegel
Neuroscience, 2002Elsevier
The amygdala plays an important role in the interpretation of emotionally significant stimuli
and has strong projections to brainstem regions regulating muscle tone and sleep.
Cataplexy, a symptom of narcolepsy, is a loss of muscle tone usually triggered by sudden,
strong emotions. Extracellular single-unit recordings were carried out in the amygdala of
narcoleptic dogs to test the hypothesis that abnormal activity of a subpopulation of amygdala
neurons is linked to cataplexy. Of the 218 cells recorded, 31 were sleep active, 78 were …
The amygdala plays an important role in the interpretation of emotionally significant stimuli and has strong projections to brainstem regions regulating muscle tone and sleep. Cataplexy, a symptom of narcolepsy, is a loss of muscle tone usually triggered by sudden, strong emotions. Extracellular single-unit recordings were carried out in the amygdala of narcoleptic dogs to test the hypothesis that abnormal activity of a subpopulation of amygdala neurons is linked to cataplexy. Of the 218 cells recorded, 31 were sleep active, 78 were active in both waking and rapid-eye-movement sleep, 88 were maximally active during waking, and 21 were state independent. Two populations of cells showed a significant change in activity with cataplexy. A population of sleep active cells localized to central and basal nucleus increased discharges prior to and during cataplexy. A population of wake active cells localized to the cortical nucleus decreased activity prior to and during cataplexy. We hypothesize that these cell populations have a role in mediation or modulation of cataplexy through interactions with meso-pontine regions controlling atonia. The anticholinesterase physostigmine, at doses which increased cataplexy, did not alter the activity of the cataplexy-related cells or of other amygdala cells, suggesting that its effect on cataplexy is mediated ‘downstream’ of the amygdala. The α-1 blocker prazosin, at doses which increased cataplexy, increased discharge in a subgroup of the cataplexy active cells and in a number of other amygdala cells, indicating that prazosin may modulate cataplexy by its action on amygdala cells or their afferents.
Elsevier